10 November 2015 - Deborah Wilkes
Archived
Moberg Pharma is evaluating options for launching its Emtrix OTC nail treatment in the UK, Poland and a number of other European Union countries. The Swedish company has also entered into a development agreement with Colep for MOB-015, a novel topical terbinafine formulation for treating nail fungus.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.